Michael's regular comments on linkedin are a good example why a CSO and a COO as well as the rest of the team are are essential at this stage of Pharmausts evolution. This allows the CEO to take a broader view and drive the company.
Pharmaust is now unrecognizable to the company it was 12 months ago, I like that the strategy is taking MPL to commercialization, and building a company of substance. This also says while all offers will be considered, they will need to be serious offers.
Cheers
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-427
-
- There are more pages in this discussion • 552 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 81374 | 4 |
View Market Depth
| Last trade - 10.05am 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable